Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06344650

Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.

Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess. Cross-sectional and Prospective Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
IRCCS San Raffaele · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Prospective observational clinical, molecular, translational study aimed at identifying the main determinants and predictive factors of fragility fracture risck in acromegaly patients

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood sampleCollection of blood serum for molecular and biochemical tests
DIAGNOSTIC_TESTRadiological testsPerformance of radiological tests (DXA, VFA, TBS, BSi, HR-pQCT) and DXA morphometry
OTHERQuestionnairesCompilation of questionnaires (AcroQol, SF-36)

Timeline

Start date
2023-04-30
Primary completion
2024-10-31
Completion
2026-04-01
First posted
2024-04-03
Last updated
2024-08-22

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06344650. Inclusion in this directory is not an endorsement.

Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess. (NCT06344650) · Clinical Trials Directory